Russell P Tracy

Author PubWeight™ 404.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002 35.63
2 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 23.97
3 Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 2006 6.58
4 Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008 6.00
5 Lifetime risks of cardiovascular disease. N Engl J Med 2012 5.95
6 HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013 5.90
7 Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008 5.86
8 Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med 2014 5.47
9 Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol 2006 5.28
10 Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002 4.97
11 Inflammation as a risk factor for atrial fibrillation. Circulation 2003 4.95
12 Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 2013 4.85
13 Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 2012 4.63
14 Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002 4.58
15 Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004 4.54
16 The 6-min walk test: a quick measure of functional status in elderly adults. Chest 2003 4.29
17 Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003 3.76
18 Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011 3.68
19 Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 2008 3.61
20 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006 3.50
21 Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006 3.26
22 Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012 3.21
23 Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet 2011 3.07
24 Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 2002 3.04
25 Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 2013 2.98
26 Candidate gene association resource (CARe): design, methods, and proof of concept. Circ Cardiovasc Genet 2010 2.91
27 Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation 2003 2.88
28 Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis 2013 2.82
29 n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2003 2.82
30 CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 2014 2.75
31 Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005 2.71
32 The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging 2010 2.69
33 Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation 2006 2.57
34 Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis 2011 2.56
35 Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol 2003 2.49
36 C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 2005 2.48
37 Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 2005 2.44
38 Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2002 2.41
39 Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2007 2.36
40 The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. Ophthalmology 2003 2.36
41 Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood 2009 2.27
42 Prospective study of particulate air pollution exposures, subclinical atherosclerosis, and clinical cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). Am J Epidemiol 2012 2.23
43 Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004 2.21
44 Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci 2011 2.19
45 Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog 2013 2.06
46 Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010 2.05
47 Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002 2.04
48 Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005 1.99
49 Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2006 1.97
50 Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension 2012 1.96
51 Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004 1.93
52 CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 2004 1.93
53 Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation 2011 1.91
54 Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002 1.85
55 The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort. J Clin Endocrinol Metab 2004 1.84
56 Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation 2013 1.77
57 In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 2002 1.70
58 The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2006 1.67
59 Sleep-disordered breathing and prothrombotic biomarkers: cross-sectional results of the Cleveland Family Study. Am J Respir Crit Care Med 2010 1.62
60 The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004 1.62
61 Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study. J Am Geriatr Soc 2006 1.59
62 Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis. Eur Heart J 2010 1.58
63 Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002 1.55
64 Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 2004 1.55
65 Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans. Hum Genet 2010 1.54
66 Inflammation biomarkers and near-term death in older men. Am J Epidemiol 2007 1.52
67 Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke 2008 1.48
68 Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. AIDS 2010 1.46
69 Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2. Arterioscler Thromb Vasc Biol 2014 1.45
70 Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study. Int J Stroke 2014 1.45
71 Treatment-related changes in serum lipids and inflammation: clinical relevance remains unclear. Analyses from the Women's Interagency HIV study. AIDS 2013 1.43
72 Age-related differences in skeletal muscle protein synthesis: relation to markers of immune activation. Am J Physiol Endocrinol Metab 2004 1.42
73 Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol 2008 1.42
74 Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. Diabetes 2002 1.42
75 Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med 2005 1.41
76 Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum 2008 1.41
77 Diabetic cardiomyopathy and subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2006 1.40
78 The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc 2004 1.38
79 Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr 2012 1.37
80 Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002 1.35
81 Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics 2011 1.34
82 The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 2002 1.33
83 Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2009 1.33
84 C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003 1.32
85 Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 2003 1.32
86 Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 2003 1.31
87 The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J Kidney Dis 2004 1.31
88 C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation 2005 1.29
89 Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004 1.29
90 Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin Chem 2006 1.27
91 Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail 2009 1.27
92 Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation. Blood 2012 1.26
93 Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study. Arterioscler Thromb Vasc Biol 2003 1.21
94 The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Diabetes Care 2009 1.21
95 10-year follow-up of subclinical cardiovascular disease and risk of coronary heart disease in the Cardiovascular Health Study. Arch Intern Med 2006 1.21
96 A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2010 1.21
97 Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes. Circulation 2006 1.17
98 Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 2012 1.15
99 Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 2002 1.15
100 Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 2003 1.15
101 C-reactive protein and myocardial infarction. J Clin Epidemiol 2002 1.14
102 Population differences in proinflammatory biology: Japanese have healthier profiles than Americans. Brain Behav Immun 2010 1.14
103 Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation 2012 1.14
104 Relationship between C-reactive protein levels and regional left ventricular function in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2007 1.13
105 Physical fitness and C-reactive protein level in children and young adults: the Columbia University BioMarkers Study. Pediatrics 2003 1.12
106 Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med 2006 1.11
107 Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study). Am J Cardiol 2005 1.11
108 Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study. Atherosclerosis 2009 1.11
109 Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 2005 1.09
110 Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol 2005 1.08
111 Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. Eur Heart J 2011 1.08
112 Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol 2012 1.08
113 Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 2010 1.07
114 Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe). Blood 2010 1.07
115 IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 2006 1.07
116 Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 2003 1.07
117 Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study. Diabetes Care 2012 1.06
118 Elevated serum C-reactive protein levels and advanced atherosclerosis in youth. Arterioscler Thromb Vasc Biol 2005 1.05
119 Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure. Am J Cardiol 2009 1.05
120 HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc 2013 1.04
121 Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study. Obesity (Silver Spring) 2013 1.04
122 Frequency and type of seafood consumed influence plasma (n-3) fatty acid concentrations. J Nutr 2008 1.04
123 Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. PLoS One 2013 1.03
124 Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure. Circ Heart Fail 2012 1.03
125 Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 2007 1.03
126 Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis. Circ Cardiovasc Genet 2011 1.03
127 The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis. Am J Epidemiol 2011 1.02
128 Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls. Am J Cardiol 2008 1.02
129 The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium. Am J Epidemiol 2013 1.02
130 Alcohol consumption and lipoprotein subclasses in older adults. J Clin Endocrinol Metab 2007 1.01
131 Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am J Hum Genet 2012 1.01
132 Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care 2011 1.01
133 Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis 2012 1.01
134 Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. Atherosclerosis 2007 1.01
135 The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women. Am J Med 2003 1.00
136 Inflammation and stress-related candidate genes, plasma interleukin-6 levels, and longevity in older adults. Exp Gerontol 2009 1.00
137 Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 5: gender-related risk factors for ischemic heart disease. Circulation 2004 1.00
138 Association of sICAM-1 and MCP-1 with coronary artery calcification in families enriched for coronary heart disease or hypertension: the NHLBI Family Heart Study. BMC Cardiovasc Disord 2007 1.00
139 The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study. Circ Heart Fail 2011 0.99
140 Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biol Psychol 2010 0.99
141 Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J Clin Endocrinol Metab 2012 0.98
142 Venous thrombosis in the elderly: more questions than answers. Blood 2007 0.98
143 Methylomics of gene expression in human monocytes. Hum Mol Genet 2013 0.97
144 Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study. BMC Infect Dis 2013 0.97
145 Plasma free fatty acids and risk of atrial fibrillation (from the Cardiovascular Health Study). Am J Cardiol 2012 0.97
146 Factors associated with low levels of subclinical vascular disease in older adults: multi-ethnic study of atherosclerosis. Prev Cardiol 2009 0.96
147 Common coding variants of the HNF1A gene are associated with multiple cardiovascular risk phenotypes in community-based samples of younger and older European-American adults: the Coronary Artery Risk Development in Young Adults Study and The Cardiovascular Health Study. Circ Cardiovasc Genet 2009 0.96
148 Gene variants associated with ischemic stroke: the cardiovascular health study. Stroke 2008 0.95
149 Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. J Atheroscler Thromb 2009 0.95
150 High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. J Clin Endocrinol Metab 2008 0.94
151 Commentary: lifelong prevention of atherosclerosis: the critical importance of major risk factor exposures. Int J Epidemiol 2002 0.94
152 Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis. Blood 2007 0.94
153 Linkage study of fibrinogen levels: the Strong Heart Family Study. BMC Med Genet 2008 0.94
154 Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. Obes Res 2003 0.93
155 Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults. Stroke 2011 0.93
156 Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Arterioscler Thromb Vasc Biol 2011 0.93
157 Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 2008 0.93
158 Alcohol consumption and inflammatory markers in older adults: the Cardiovascular Health Study. Atherosclerosis 2004 0.92
159 USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies. Arterioscler Thromb Vasc Biol 2007 0.92
160 Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 2005 0.92
161 Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study. Circ Heart Fail 2013 0.92
162 A variational Bayes discrete mixture test for rare variant association. Genet Epidemiol 2014 0.92
163 Genetic determination of acute phase reactant levels: the strong heart study. Hum Hered 2004 0.91
164 Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study. Obesity (Silver Spring) 2008 0.91
165 Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans. Am J Cardiol 2008 0.91
166 beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study. Am J Hypertens 2005 0.91
167 C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis. Am J Cardiol 2008 0.91
168 Plasma fatty acid-binding protein 4, nonesterified fatty acids, and incident diabetes in older adults. Diabetes Care 2012 0.89
169 Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. Am Heart J 2009 0.89
170 Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1. Circulation 2002 0.89
171 Inflammation in cardiovascular disease: cart, horse or both--revisited. Arterioscler Thromb Vasc Biol 2002 0.89
172 Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study. J Lipid Res 2012 0.88
173 Age as a modulator of inflammatory cardiovascular risk factors. Arterioscler Thromb Vasc Biol 2011 0.88
174 Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study. Eur J Heart Fail 2012 0.88
175 Association between depression and coronary artery calcification in women with systemic lupus erythematosus. Rheumatology (Oxford) 2009 0.88
176 Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study. Int J Cardiol 2013 0.88
177 Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study. Circ Cardiovasc Genet 2012 0.87
178 Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients. J Acquir Immune Defic Syndr 2013 0.87
179 Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 2013 0.87
180 Von Willebrand factor and the right ventricle (the MESA-Right Ventricle Study). Am J Cardiol 2012 0.86
181 Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J Appl Physiol (1985) 2005 0.86
182 Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia. Hum Mol Genet 2013 0.86
183 Fibrosis-related biomarkers and risk of total and cause-specific mortality: the cardiovascular health study. Am J Epidemiol 2014 0.86
184 HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction. J Acquir Immune Defic Syndr 2012 0.86
185 Associations between common fibrinogen gene polymorphisms and cardiovascular disease in older adults. The Cardiovascular Health Study. Thromb Haemost 2008 0.86
186 Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial. PLoS One 2012 0.85
187 Dietary fatty acids, hemostasis, and cardiovascular disease risk. J Am Diet Assoc 2004 0.85
188 Association between depression and vascular disease in systemic lupus erythematosus. J Rheumatol 2011 0.85
189 Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients. Adv Chronic Kidney Dis 2007 0.84
190 Transforming growth factor beta-1 and incidence of heart failure in older adults: the Cardiovascular Health Study. Cytokine 2012 0.84
191 The association of plasma fibrinogen concentration with diabetic microvascular complications in young adults with early-onset of type 2 diabetes. Diabetes Res Clin Pract 2008 0.84
192 No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study. Thromb Haemost 2002 0.83
193 Traditional and novel risk factors in older adults: cardiovascular risk assessment late in life. Am J Geriatr Cardiol 2004 0.83
194 Common promoter polymorphisms of inflammation and thrombosis genes and longevity in older adults: the cardiovascular health study. Atherosclerosis 2005 0.83
195 Prospective association between inflammatory markers and progression of coronary artery calcification in adults with and without type 1 diabetes. Diabetes Care 2013 0.82
196 The five cardinal signs of inflammation: Calor, Dolor, Rubor, Tumor ... and Penuria (Apologies to Aulus Cornelius Celsus, De medicina, c. A.D. 25). J Gerontol A Biol Sci Med Sci 2006 0.82
197 T helper cell polarization in healthy people: implications for cardiovascular disease. J Cardiovasc Transl Res 2013 0.82
198 Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans. Hum Genet 2014 0.82
199 Nonesterified fatty acids and risk of sudden cardiac death in older adults. Circ Arrhythm Electrophysiol 2012 0.82
200 The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective study. BMC Cardiovasc Disord 2011 0.81
201 Adiposity is associated with endothelial activation in healthy 2-3 year-old children. J Pediatr Endocrinol Metab 2009 0.81
202 A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium. Hum Mol Genet 2011 0.81
203 Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet 2010 0.81
204 Inflammatory markers and negative mood symptoms following exercise withdrawal. Brain Behav Immun 2008 0.81
205 Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study. J Bone Miner Res 2014 0.80
206 Subclinical hypothyroidism, weight change, and body composition in the elderly: the Cardiovascular Health Study. J Clin Endocrinol Metab 2014 0.79
207 Study of the relationship between the interleukin-6 gene and obstructive sleep apnea. Clin Transl Sci 2010 0.79
208 Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertension. Ann Am Thorac Soc 2015 0.79
209 A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study. Obesity (Silver Spring) 2008 0.79
210 C-reactive protein, heart disease risk, and the popular media. Arch Intern Med 2005 0.78
211 The determinants of plasma plasminogen activator inhibitor-1 levels differ for American and Japanese men aged 40-49. Diabetes Res Clin Pract 2005 0.78
212 Fibrinogen and CRP in Israeli families: genetic and environmental sources of concentrations and longitudinal changes. Atherosclerosis 2006 0.78
213 CRP gene variation and risk of community-acquired pneumonia. Respirology 2009 0.77
214 Association analysis of the plasminogen activator inhibitor-1 4G/5G polymorphism in Hispanics and African Americans: the IRAS family study. Hum Hered 2004 0.77
215 HIV and coronary artery calcium score: comparison of the Hawaii Aging with HIV Cardiovascular Study and Multi-Ethnic Study of Atherosclerosis (MESA) cohorts. HIV Clin Trials 2015 0.77
216 Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort. Am J Kidney Dis 2005 0.77
217 Low-Density Lipoprotein Cholesterol Concentrations and Association of High-Sensitivity C-Reactive Protein Concentrations With Incident Coronary Heart Disease in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 2015 0.77
218 The role of the immune system in the insulin resistance syndrome. Curr Diab Rep 2002 0.76
219 Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? J Acquir Immune Defic Syndr 2016 0.76
220 Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? J Acquir Immune Defic Syndr 2016 0.76
221 Common FABP4 genetic variants and plasma levels of fatty acid binding protein 4 in older adults. Lipids 2013 0.75
222 Association of markers of hemostasis with death in HIV-infected women. J Acquir Immune Defic Syndr 2014 0.75
223 Do differences in risk factors explain the lower rates of coronary heart disease in Japanese versus U.S. women? J Womens Health (Larchmt) 2013 0.75
224 Monthly haemostatic factor variability in women and men. Eur J Clin Invest 2014 0.75
225 Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1. J Acad Nutr Diet 2014 0.75
226 Oxidized LDL and the metabolic syndrome. Arterioscler Thromb Vasc Biol 2006 0.75
227 Alcohol consumption, interleukin-6 and apolipoprotein E genotypes, and concentrations of interleukin-6 and serum amyloid P in older adults. Am J Clin Nutr 2007 0.75
228 D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr 2016 0.75
229 Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study. Menopause 2009 0.75
230 Functional variants in the lymphotoxin-alpha gene predict cardiovascular disease in dialysis patients. J Am Soc Nephrol 2006 0.75
231 HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer. J Acquir Immune Defic Syndr 2017 0.75